Diagnosing CIDP involves peripheral nervous system testing, cerebrospinal fluid analysis, and imaging. CIDP is an immune-mediated condition affecting your peripheral nerves. It occurs when immune ...

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an uncommon cause of neck pain and radiculopathy that can ...

In Phase 2, Nuvig will test NVG-2089 as a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP), a rare disorder in which the immune system attacks myelin, the protective sheath ...

The physician will diagnose CIDP using EMG and nerve conduction velocity testing, spinal tap, MRI, and blood tests, as well as, in rare cases, a nerve biopsy. Treatment of CDIP includes ...

Nuvig Therapeutics has dosed the first subject in its multi-centre Phase II INVGOR trial of recombinant human immunoglobulin G1-crystallisable fragment (IgG1-Fc) fusion protein, NVG-2089, for ...

He noted the significant early impact on CIDP and progress in clinical milestones, including advancing empasiprubart and efgartigimod into Phase III programs. Van Hauwermeiren announced that 2025 ...

CONSHOHOCKEN, Pa., May 8, 2025 /PRNewswire/ -- The GBS | CIDP Foundation International is commemorating Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy Awareness ...

While anyone can get CIDP, people in their 50s and 60s, as well as men, are more likely to develop the condition. There’s no test to diagnose CIDP. Instead, your doctor will ask you questions ...

CIDP treatment focuses on reducing and slowing the immune processes damaging your peripheral nervous system. It includes corticosteroids, intravenous immunoglobulin, and plasma exchange, but new ...

Doctors can distinguish CIDP from other neurological conditions in several ways, including using test results, noting when symptoms start, how they progress, and how long they persist. Doctors may ...